60% of lung cancer patients saw COVID-19-related treatment delays, study finds

Wednesday, September 16, 2020 - 10:00 in Health & Medicine

Nearly 60% of people undergoing treatment for lung cancer experienced disruptions in care this spring because of the COVID-19 pandemic, according to an analysis published Wednesday by JAMA Oncology.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net